Advertisement

Topics

Adlai Nortye gets Reolysin rights from Oncolytics Biotech

15:40 EDT 13 Mar 2018 | Elsevier Business Intelligence

Oncolytics Biotech Inc. granted Adlai Nortye exclusive rights to develop and sell its cancer therapy Reolysin (pelareorep) in...

Original Article: Adlai Nortye gets Reolysin rights from Oncolytics Biotech

NEXT ARTICLE

More From BioPortfolio on "Adlai Nortye gets Reolysin rights from Oncolytics Biotech"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...